The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
About three months after Victrelis was approved in Europe as the third drug in a triple combination therapy for Hepatitis C, the European Union grants approval to Incivo -Victrelis's only competition.
Continue reading »Fatigue is a problem frequently experienced by those with chronic hepatitis. Fortunately, there are several different kinds of approaches that can help mitigate fatigue.
Continue reading »Squalamine, a molecule found in the dogfish shark, is showing remarkable potential for fighting several diseases - including Hepatitis B and Hepatitis C.
Continue reading »Using response-guided therapy, the new three drug regimen can cure Hepatitis C in just six months.
Continue reading »Upon identifying weaknesses in the Hepatitis C virus, Australian researchers believe their discovery could lead to a vaccine.
Continue reading »With the recent approval of the direct acting antivirals (DAA) Incivek and Victrelis, Hepatitis C treatment is improving. However, the next crop of DAAs has the potential to make Hepatitis C treatment even better.
Continue reading »As their popularity with the aging population grows, assisted living facilities have a duty to prevent the spread of viral hepatitis.
Continue reading »Showing potential to be a monotherapy for chronic Hepatitis C infection, the FDA has awarded Pharmasset with fast track status for its drug in development, PSI-938.
Continue reading »For people new to treatment and those who have failed a previous treatment attempt, Vertex's Incivek can now be prescribed to Canadians with chronic Hepatitis C.
Continue reading »Hepatitis C patients in the UK can now increase their odds of beating the virus with Victrelis.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
